AI assistant
DEXCOM INC — Director's Dealing 2010
May 12, 2010
30198_dirs_2010-05-12_bd67f5f2-8621-4241-a5d7-2edad0d971d8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2010-05-10
Reporting Person: GREGG TERRANCE H (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-05-10 | Common Stock | P | 10000 | $9.72 | Acquired | 639263 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 30000 | Direct |
| Common Stock | 11461 | Indirect |
Footnotes
F1: Included in this number are 92,213 shares restricted and subject to repurchase by DexCom, provided that DexCom's right to repurchase lapses with respect to 1/30th of the shares each month beginning one month following the grant date of January 2, 2008.
Also included in this number are 146,250 restricted stock units subject to vesting with respect to 1/36 of the units each month beginning one month following the grant date of March 12, 2010.
F2: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.